2016
DOI: 10.1097/wco.0000000000000323
|View full text |Cite
|
Sign up to set email alerts
|

Recent achievements in stem cell-mediated myelin repair

Abstract: This review summarizes recent developments and findings related to pharmacological myelin repair as well as to the modulation/application of stem cells with the aim to restore defective myelin sheaths.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 110 publications
(87 reference statements)
0
3
0
Order By: Relevance
“…In contrast to rat neural stem cells, human NSC differentiation into oligodendrocytes appears to be impaired and delayed (Jadasz et al, ) indicating that research efforts should be dedicated to the derivation of improved new protocols for iPSC‐derived oligodendrocyte generation. To study possible MSC dependent pro‐oligodendroglial effects in a purely human system, i.e., responses of human neural stem cells following supply of human fetal mesenchymal stem cell secreted factors, we stimulated human iPSC‐derived NSCs with H37 MSC‐CM.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…In contrast to rat neural stem cells, human NSC differentiation into oligodendrocytes appears to be impaired and delayed (Jadasz et al, ) indicating that research efforts should be dedicated to the derivation of improved new protocols for iPSC‐derived oligodendrocyte generation. To study possible MSC dependent pro‐oligodendroglial effects in a purely human system, i.e., responses of human neural stem cells following supply of human fetal mesenchymal stem cell secreted factors, we stimulated human iPSC‐derived NSCs with H37 MSC‐CM.…”
Section: Resultsmentioning
confidence: 99%
“…Our findings unraveled a certain degree of heterogeneity among myelin repair mediating cells when it comes to intrinsic regulators and mechanisms but at the same time showed a remarkable stability of potent exogenous stimuli acting across species. Based on their immunomodulatory actions, systemic application of mesenchymal stem cells is currently under investigation in clinical trials (Jadasz et al, ; Oh et al, ). However, for a prospective biomedical translation, it would be desirable that active pro‐oligodendrogenic and anti‐astrocytic components are identified first and then applied specifically—a strategy to which our here described findings might contribute.…”
Section: Discussionmentioning
confidence: 99%
“…In AHSCT, the dysregulated immune system of a patient is eliminated by chemotherapy whereupon previously isolated HSCs from the patient’s bone marrow are transplanted to generate a new immune system. Injection of MSCs, also derived from the patient’s bone marrow, is related to the many beneficial and regenerative effects that could be attributed to these cells [54,55]. While both treatments have yielded rather positive results [56], clinical trials so far have been preliminary and included low patient numbers only.…”
Section: Endogenous Versus Exogenous Stem Cell-mediated Repairmentioning
confidence: 99%